Researchers evaluate benmelstobart, with or without anlotinib, for use as consolidation therapy after chemoradiotherapy in ...

In a phase 2 trial, oral brepocitinib improves skin disease activity and quality of life in adults with cutaneous sarcoidosis ...

Even in patients most likely to benefit, a 25-year follow-up in the landmark COURAGE trial has not shown percutaneous ...

In patients with aortic stenosis accompanied by at least one risk factor, transcatheter valve replacement produces a large ...

A phase 2 trial compares dual-targeted CAR T-cell therapy with R-GemOx as second-line treatment for patients with relapsed or ...

Elevated pulmonary artery systolic pressure is linked to lower survival after a heart transplant, despite pulmonary vascular ...

Textile dye allergy remains a concern in Italy, with nearly 4% of patch‑tested patients reacting and roughly 60% of reactions ...

With the highest objective response rate in a phase 3 trial, Serono says its CSF-1R inhibitor is a potential 'best-in-class.' ...

Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead ...

An education intervention for advanced CKD patients on treatment options shows benefits in informed care-planning decisions, ...

The use of fluorescence guidance in thyroidectomy improves identification and vascular preservation of the parathyroid glands ...